Cargando…
Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell
BACKGROUND: Patients with stage II deficient mismatch repair (dMMR) show a better prognosis than patients with colorectal cancer (CRC) with proficient mismatch repair (pMMR). However, this beneficial effect is decreased in advanced stages of the disease. This study was conducted to investigate the p...
Autores principales: | Wang, Bingyan, Li, Fei, Guo, Limei, Lu, Siyi, Ma, Junren, Ma, Yanpeng, Meng, Yan, Wang, Junwei, Zhou, Xin, Fu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414758/ https://www.ncbi.nlm.nih.gov/pubmed/32767974 http://dx.doi.org/10.1186/s12957-020-01970-0 |
Ejemplares similares
-
Comparison of Clinical Outcomes and Pathological Characteristics of Self-Expandable Stent Bridge to Surgery and Emergency Surgery in Obstructive Colon Cancer
por: Wang, Bingyan, et al.
Publicado: (2020) -
Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
por: Vlahović, Ivan, et al.
Publicado: (2023) -
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
por: Schweizer, Michael T., et al.
Publicado: (2016) -
Loss of mismatch repair promotes a direct selective advantage in human stem cells
por: Madden-Hennessey, Kirby, et al.
Publicado: (2022) -
Prognostic and Predictive Values of Mismatch Repair Deficiency in Non-Metastatic Colorectal Cancer
por: Jin, Zhaohui, et al.
Publicado: (2021)